Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DOCTOR, V. M.
Right arrow Articles by SHULLENBERGER, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DOCTOR, V. M.
Right arrow Articles by SHULLENBERGER, C. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1959, Vol. 14, No. 3, pp. 274-278.
© 1959 American Society of Hematology, Inc.

Effect of Myleran and 6-Mercaptopurine (6-MP) on the Serum Level of Vitamin B12 in Chronic Myelocytic Leukemia

V. M. DOCTOR 1, D. E. BERGSAGEL 1, and C. C. SHULLENBERGER 1

1 Department of Medicine, University of Texas M. D. Anderson Hospital and Tumor Institute, Houston, Texas.

Serum vitamin B12 determinations and the total leukocyte counts were made at regular intervals in chronic myelocytic leukemia patients before, during and after therapy with 6-MP or Myleran. The results indicate that a reduction in total leukocytes following therapy is followed by a gradual lowering of serum vitamin B12. The levels of serum vitamin B12 at the completion of therapy may be related to the duration of remission.

Submitted on May 27, 1958
Accepted on July 30, 1958


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1959 by American Society of Hematology         Online ISSN: 1528-0020